Rethinking conservation and restoration strategies of endangered and key
medicinal Clavicarpa plants in Yunnan-Kweichow Plateau's Karst areas
under climate change
Abstract
The Clavicarpa species, valued for their pharmaceutical, ornamental, and
economic importance, exhibit notable rarity and endemism in the Karst
areas of the Yunnan-Kweichow Plateau in China. These species face
significant threats from habitat loss and fragmentation, leading to a
decline in biodiversity. To mitigate these threats, the MaxEnt algorithm
was employed to analyze current and future distribution patterns, with a
particular focus on the influence of climate variables in predicting
potential distribution shifts and assessing extinction risks under the
optimistic SSP1-2.6 and the pessimistic SSP5-8.5 socioeconomic
scenarios. The EC-Earth3-Veg, MRI-ESM2-0, and MPI-ESM1-2-HR models were
utilized for conservation status assessment and project future
distributions for four time periods: the present, 2030s, 2050s, and
2070s. The minimum temperature during the coldest month (Bio 6) was
identified as the most critical environmental factor, influencing both
habitat contraction and expansion. Our modeling indicates that regions
such as South, Central, and East China, particularly areas east of the
Aihui-Tengchong line and south of the Yangtze River, exhibit the highest
suitability for Clavicarpa species within the geographical coordinates
of 18° N-45° N and 97° E-120° E. Conversely, climate change projections
suggest a habitat expansion for I. claviger, I. tubulosa, I. pritzelii,
and I. apalophylla, while I. guizhouensis and I. wilsonii face increased
extinction risks. Specifically, I. claviger, I. tubulosa, and I.
apalophylla are expected to shift northward, necessitating potential
relocation to southern regions, while I. guizhouensis and I. wilsonii
are projected to experience habitat losses of over 23.94% and 9.13%,
respectively. Our research provides a robust scientific foundation for
the conservation and sustainable utilization of these important
pharmaceutical species and offers a framework for effective biodiversity
management. We recommend using protected areas as a basis for the future
conservation, breeding, cultivation, and utilization of Clavicarpa
species.